Nurse Practitioner in Dry Prong, LA Accepting Medicare
4 Nurse Practitioner nurses found. Showing 1 - 4
 Amy Brewer, Nurse Practitioner - Family Medicare: Medicare Enrolled Practice Location: 800 Grove St, Dry Prong, LA 71423 Phone: 318-569-8298 |
Kimberly J Sills, FNP-C Nurse Practitioner - Family Medicare: Accepting Medicare Assignments Practice Location: 500 Mosley Rd, Dry Prong, LA 71423 Phone: 318-359-8034 |
Dana Renee Guirlando, DNP, FNP-C Nurse Practitioner - Family Medicare: Not Enrolled in Medicare Practice Location: 21730 Highway 167 Ste B, Dry Prong, LA 71423 Phone: 318-545-6564 Fax: 318-625-0683 |
Page J Tarter, FNP-C Nurse Practitioner - Family Medicare: Not Enrolled in Medicare Practice Location: 17763 Highway 167, Dry Prong, LA 71423 Phone: 318-899-5276 Fax: 318-899-5932 |
News Archive
The Center for Applied Nanotechnology presents a ready-to-use reagent for the detection of poly-histidine tagged proteins in Blot assays
The nano-experts from the Center for Applied Nanotechnology (CAN) GmbH expand their product portfolio by CANdots® Series G - His Detect, which is a ready-to-use reagent for the detection of poly-histidine tagged proteins in Blot assays. It is easy to handle, highly sensitive as well as time saving compared to standard methods available on the market, e.g. ECL.
Breath test shows promise for detection of head-and-neck cancers
Scientists reveal that an 'electronic nose' can distinguish between molecules found in the breath of head-and-neck cancer patients and those of healthy people, according to the results of a small, initial study published in the British Journal of Cancer, today.
Five-year $10.7M grant to study control, prevention of sexually-transmitted infections
The University of Maryland Schools of Dentistry (UM SOD) and Medicine (UM SOM) jointly announced today that they have received a five-year $10.7 million grant award from the National Institute of Allergy and Infectious Diseases (NIAID) of the National Institutes of Health to study the causes, prevention and treatment of sexually-transmitted diseases (STDs).
Combination therapy appears to improve outcome of women with late-stage ovarian cancer
The combination of decitabine and carboplatin appears to improve the outcome of women who have late-stage ovarian cancer. In an upcoming issue of the journal Cancer (online today), Indiana University researchers report four of 10 patients who participated in a phase I clinical trial had no disease progression after six months of treatment. One patient experienced complete resolution of tumor tissue for a period of time.
› Verified 5 days ago